In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $14.38 in the last session, down -0.35% from day before closing price of $14.43. In other words, the price has decreased by -$0.35 from its previous closing price. On the day, 1.46 million shares were traded. ALHC stock price reached its highest trading level at $14.41 during the session, while it also had its lowest trading level at $14.07.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 24 ’25 when Kardes Hakan sold 14,500 shares for $14.98 per share. The transaction valued at 217,277 led to the insider holds 295,444 shares of the business.
Kardes Hakan sold 10,500 shares of ALHC for $157,370 on Jan 21 ’25. The Chief Experience Officer now owns 309,944 shares after completing the transaction at $14.99 per share. On Jan 21 ’25, another insider, HAKAN KARDES, who serves as the Officer of the company, bought 25,000 shares for $14.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 2756588544 and an Enterprise Value of 2596880896. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12 while its Price-to-Book (P/B) ratio in mrq is 24.05. Its current Enterprise Value per Revenue stands at 1.052 whereas that against EBITDA is -27.72.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.51, which has changed by 1.2268519 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $15.82, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 11.63%, while the 200-Day Moving Average is calculated to be 39.78%.
Shares Statistics:
According to the various share statistics, ALHC traded on average about 2.00M shares per day over the past 3-months and 1886000 shares per day over the past 10 days. A total of 191.60M shares are outstanding, with a floating share count of 92.32M. Insiders hold about 51.84% of the company’s shares, while institutions hold 44.02% stake in the company. Shares short for ALHC as of 1738281600 were 8054907 with a Short Ratio of 4.64, compared to 1735603200 on 9577322. Therefore, it implies a Short% of Shares Outstanding of 8054907 and a Short% of Float of 6.5600000000000005.
